M
Maria Fesatidou
Researcher at Aristotle University of Thessaloniki
Publications - 12
Citations - 330
Maria Fesatidou is an academic researcher from Aristotle University of Thessaloniki. The author has contributed to research in topics: Docking (molecular) & Chemistry. The author has an hindex of 5, co-authored 9 publications receiving 147 citations.
Papers
More filters
Journal ArticleDOI
Thiazoles and Thiazolidinones as COX/LOX Inhibitors
TL;DR: This review focuses on the biological activity of several thiazole and thiazolidinone derivatives as COX-1/COX-2 and LOX inhibitors, which could provide numerous therapeutic advantages in terms of anti-inflammatory activity, improved gastric protection and safer cardiovascular profile compared to conventional NSAIDs.
Journal ArticleDOI
Thiazole Ring-A Biologically Active Scaffold.
TL;DR: A literature survey regarding the topics from the year 2015 up to now was carried out as mentioned in this paper, where nearly 124 research articles were found, critically analyzed, and arranged regarding the synthesis and biological activities of thiazoles derivatives in the last 5 years.
Journal ArticleDOI
5-Adamantan thiadiazole-based thiazolidinones as antimicrobial agents. Design, synthesis, molecular docking and evaluation.
Maria Fesatidou,Panagiotis Zagaliotis,Charalampos Camoutsis,Anthi Petrou,Phaedra Eleftheriou,Christophe Tratrat,Micheline Haroun,Athina Geronikaki,Ana Ćirić,Marina Soković +9 more
TL;DR: The best antibacterial potential against ATCC and resistant strains was observed for compound 8 (2-{[5-(adamantan-1-yl)-1,3,4-thiadiazol-2-yl]-imino}-5-(4-nitrobenzylidene)- 1,3thiazolidin-4-one) and it was found that compound 8 appeared again to be the most potent.
Journal ArticleDOI
Aldose reductase and protein tyrosine phosphatase 1B inhibitors as a promising therapeutic approach for diabetes mellitus.
Antonios Kousaxidis,Anthi Petrou,Vasiliki Lavrentaki,Maria Fesatidou,Ioannis Nicolaou,Athina Geronikaki +5 more
TL;DR: A variety of diverse scaffolds are presented in this review for the future design of potent and selective inhibitors of aldose reductase and protein tyrosine phosphatase 1B based on the most important structural features of both enzymes.
Journal ArticleDOI
Synthesis and biological evaluation of potent antifungal agents.
TL;DR: A critical need exists for new antifungal agents with fewer side effecgts to treat these life-threatening fungal infections.